| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745875 | Parkinsonism & Related Disorders | 2013 | 4 Pages |
Abstract
Combination therapy and comorbidity relevant to cardiac QT prolongation are common in patients with Parkinson's disease. Strategies to reduce the proportion of patients at risk from iatrogenic adverse cardiac events are warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Naveed M. Malek, Katherine A. Grosset, David Stewart, Graeme J.A. Macphee, Donald G. Grosset,